Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trastuzumab-deruxtecan In Metastatic Breast Cancer Patients: A ReaL World Study of Chinese Population

NCT06945224 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06945224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06945224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trastuzumab-deruxtecan In Metastatic Breast Cancer Patients: A ReaL World Study of Chinese Population
Lead sponsor
Fudan University
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2024
Completion date
June 30, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic, treatment efficacy